This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Author: Avi Kapoor | June 05, 2025 03:17pm
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Wedbush analyst David Nierengarten initiated coverage on Telix Pharmaceuticals Limited (NASDAQ:TLX) with an Outperform rating and announced a price target of $22. Telix Pharmaceuticals shares closed at $17.48 on Wednesday. See how other analysts view this stock.
Jefferies analyst Emma Schwartz initiated coverage on Excelerate Energy, Inc. (NYSE:EE) with a Buy rating and announced a price target of $39. Excelerate Energy shares closed at $29.69 on Wednesday. See how other analysts view this stock.
Craig-Hallum analyst Albert Lowe initiated coverage on Atossa Therapeutics, Inc. (NASDAQ:ATOS) with a Buy rating and announced a price target of $4. Atossa Therapeutics shares closed at $0.8571 on Wednesday. See how other analysts view this stock.
Morgan Stanley analyst Joshua Pokrzywinski initiated coverage on Parker-Hannifin Corporation (NYSE:PH) with an Equal-Weight rating and announced a price target of $700. Parker Hannifin shares closed at $665.26 on Wednesday. See how other analysts view this stock.
Roth Capital analyst Boobalan Pachaiyappan initiated coverage on PolyPid Ltd. (NASDAQ:PYPD) with a Buy rating and announced a price target of $9. PolyPid shares closed at $2.98 on Wednesday. See how other analysts view this stock.
Considering buying EE stock? Here’s what analysts think:
